Jobs
Benefits & Perks
•Commuter Benefits
•Commuter
Required Skills
Analytical skills
Problem-solving
Communication
Research
About the Role:
- This application is for a 12-week internship role from June
- August 2026. Resume review begins in January 2026.
The Biogen Epidemiology group contributes to the mission and goals of Biogen by providing a deep understanding of patient populations and the burden of disease throughout the drug development life cycle. This is accomplished by synthesizing existing knowledge as well as designing and conducting studies related to disease prevalence and drug safety and effectiveness. The group of approximately 14 Ph.D.-level epidemiologists is organized by disease units and deployed to drug development and other internal teams. The Epidemiology team uses resources that include internally held observational datasets.
What You’ll Do:
You will be expected to work collaboratively with team members and groups across Biogen. The project will focus on answering epidemiologic questions related to neurodegenerative, neuromuscular, neuropsychiatric, and immunological diseases. Such work feeds directly into various stages of the drug development lifecycle and contributes to improving human health through better understanding of the scientific basis for responses to therapies at the population level.
Under the guidance of an Epidemiology team member, you will conduct research using secondary resources, such as literature and/or publicly available data, develop data visualizations, or other critical scientific and business topics related to the Biogen Epidemiology mission. A presentation at the end of the internship is planned. A publication on the results from the internship project may be possible.
Who You Are:
- Excellent analytical/problem-solving skills
- Background knowledge about biological science/medical science
- Familiarity with the U.S. healthcare system
- Strong written and verbal communication skills and attention to detail
To participate in the Biogen Internship or Co-op Program, students must meet the following eligibility criteria:
- Legal authorization to work in the U.S.
- At least 18 years of age prior to the scheduled start date.
- Currently enrolled in an accredited community college, college, university or skills program/apprenticeship.
Education Requirements
- Master’s-level degree (MSc or MPH) in Epidemiology (or closely related field) AND currently enrolled in a doctoral-level (PhD) program in Epidemiology/Pharmacoepidemiology.
Job Level: Internship
Additional Information:
The base compensation range for this role is:
- The actual hourly wage offered will consider the candidate’s current academic level and degree candidacy, inclusive of Associate, Bachelor’s, Master’s, JD, MD, PhD and MBA programs. It will comply with state or local minimum wage requirements specific to the job location.
In addition to compensation, Biogen offers a range of benefits designed to support our educational employees, including, but not limited to:
- Company paid holidays
- Commuter benefits
- Employee Resource Groups participation
- 80 hours of sick time per calendar year
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Total Views
0
Apply Clicks
0
Mock Applicants
0
Scraps
0
Similar Jobs

Global Culture & Inclusion Team Intern
GE Vernova · Remote

Communications & Videography Intern (Graduate - Summer)
Centene · Remote-KS

Service Monteur Apprentice door heel Nederland
Carrier · Netherlands, Remote

Tax & Treasury Intern (Summer 2026)
Dropbox · Remote - US: All locations

Intern
Tanium · Durham, NC (Hybrid); Emeryville, CA (Hybrid)
About Biogen

Biogen
PublicSpecializing in the treatment of neurological diseases.
5,001-10,000
Employees
Cambridge
Headquarters
Reviews
4.1
47 reviews
Work Life Balance
3.6
Compensation
4.7
Culture
4.1
Career
4.4
Management
3.8
84%
Recommend to a Friend
Pros
Opportunities for continuous learning and growth
Strong engineering culture with focus on code quality
Cutting-edge technology stack and interesting technical challenges
Cons
Organizational changes and restructuring can be disruptive
Fast-paced environment with tight deadlines
Work-life balance can be challenging during product launches
Salary Ranges
541 data points
Mid/L4
Senior/L5
Mid/L4 · SR Analyst, R&D Business Ops
1 reports
$131,388
total / year
Base
$114,250
Stock
-
Bonus
-
$131,388
$131,388
Interview Experience
47 interviews
Difficulty
3.5
/ 5
Duration
14-28 weeks
Offer Rate
36%
Experience
Positive 65%
Neutral 25%
Negative 10%
Interview Process
1
Phone Screen
2
Technical Interview
3
System Design
4
Behavioral
5
Team Fit
Common Questions
Tell me about a challenging project
System design question
Coding problem
Why this company
News & Buzz
FDA grants breakthrough therapy designation to Biogen’s litifilimab - Investing.com
Source: Investing.com
News
·
5w ago
Biogen’s Litifilimab Receives FDA Breakthrough Therapy Designation for Cutaneous Lupus Erythematosus, a Disease With No Targeted Treatment Options - Biogen
Source: Biogen
News
·
5w ago
FDA Accepts LEQEMBI® IQLIK™ (lecanemab-irmb) Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer’s Disease under Priority Review - Biogen
Source: Biogen
News
·
5w ago
Biogen’s Alisha Alaimo On The Company’s Next Big Commercial Build - Citeline News & Insights
Source: Citeline News & Insights
News
·
6w ago